United Therapeutics Corporation (UTHR) Capital expenditures 2016–2025
United Therapeutics Corporation (UTHR) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$520.5MFY2025 · since FY2016: $38.0M → $520.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $520.5M | +111.2% |
| FY2024 | $246.5M | +7.0% |
| FY2023 | $230.4M | +66.0% |
| FY2022 | $138.8M | +14.9% |
| FY2021 | $120.8M | +103.7% |
| FY2020 | $59.3M | -29.2% |
| FY2019 | $83.7M | -54.6% |
| FY2018 | $184.4M | +113.7% |
| FY2017 | $86.3M | +127.1% |
| FY2016 | $38.0M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice